| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.27e-24 | 114 | 77 | 18 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 6.31e-24 | 124 | 77 | 18 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.16e-23 | 137 | 77 | 18 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 CASP6 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 5.99e-22 | 192 | 77 | 19 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 CASP6 USP17L5 USP17L10 REN USP17L19 NCSTN USP17L22 USP17L15 USP17L13 USP17L18 | 3.45e-14 | 654 | 77 | 21 | GO:0008233 |
| GeneOntologyMolecularFunction | protein methyltransferase activity | KMT2B SUV39H1 FBXO11 FAM98A | 6.77e-04 | 103 | 77 | 4 | GO:0008276 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | DLG1 DLG4 | 7.89e-04 | 11 | 77 | 2 | GO:0098919 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | DLG1 DLG4 | 1.11e-03 | 13 | 77 | 2 | GO:0098879 |
| GeneOntologyMolecularFunction | fucosyltransferase activity | FUT9 FUT8 | 1.30e-03 | 14 | 77 | 2 | GO:0008417 |
| GeneOntologyMolecularFunction | methyltransferase activity | ALKBH8 KMT2B SUV39H1 FBXO11 FAM98A | 1.40e-03 | 213 | 77 | 5 | GO:0008168 |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | ALKBH8 KMT2B SUV39H1 FBXO11 FAM98A | 1.74e-03 | 224 | 77 | 5 | GO:0016741 |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.44e-24 | 125 | 75 | 18 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 3.54e-23 | 144 | 75 | 18 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 SAE1 USP17L5 FBXO11 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 3.17e-10 | 1009 | 75 | 20 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 SAE1 USP17L5 FBXO11 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 9.40e-10 | 1074 | 75 | 20 | GO:0043687 |
| GeneOntologyBiologicalProcess | N-glycan fucosylation | FUT9 FUT8 | 1.30e-04 | 5 | 75 | 2 | GO:0036071 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 PDIA5 DLG1 TMTC2 USP17L10 USP17L19 NCSTN TMEM151A USP17L22 USP17L15 USP17L13 USP17L18 | 1.83e-09 | 1293 | 80 | 22 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 PDIA5 DLG1 TMTC2 USP17L10 USP17L19 NCSTN TMEM151A USP17L22 USP17L15 USP17L13 USP17L18 | 1.99e-09 | 1299 | 80 | 22 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 PDIA5 DLG1 TMTC2 USP17L10 USP17L19 NCSTN TMEM151A USP17L22 USP17L15 USP17L13 USP17L18 | 2.96e-09 | 1327 | 80 | 22 | GO:0042175 |
| MousePheno | increased trophectoderm apoptosis | USP17L2 USP17L15 USP17L13 | 1.85e-06 | 8 | 46 | 3 | MP:0012119 |
| MousePheno | increased thymus weight | USP17L2 USP17L15 USP17L13 | 6.43e-05 | 24 | 46 | 3 | MP:0004955 |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L21 USP17L2 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 1.14e-32 | 16 | 76 | 14 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L21 USP17L2 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 1.14e-32 | 16 | 76 | 14 | IPR006861 |
| Domain | USP_CS | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L13 USP17L18 | 7.65e-25 | 66 | 76 | 16 | IPR018200 |
| Domain | UCH | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L13 USP17L18 | 2.82e-24 | 71 | 76 | 16 | PF00443 |
| Domain | USP_2 | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L13 USP17L18 | 2.82e-24 | 71 | 76 | 16 | PS00973 |
| Domain | USP_3 | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L13 USP17L18 | 3.61e-24 | 72 | 76 | 16 | PS50235 |
| Domain | USP_dom | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L13 USP17L18 | 3.61e-24 | 72 | 76 | 16 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L13 USP17L18 | 3.61e-24 | 72 | 76 | 16 | IPR001394 |
| Domain | USP_1 | USP17L7 USP17L21 USP17L2 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L13 USP17L18 | 1.94e-22 | 70 | 76 | 15 | PS00972 |
| Domain | MAGUK_N_PEST | DLG1 DLG4 | 9.75e-05 | 4 | 76 | 2 | PF10608 |
| Domain | PDZ_assoc | DLG1 DLG4 | 9.75e-05 | 4 | 76 | 2 | PF10600 |
| Domain | DLG1_PEST_dom | DLG1 DLG4 | 9.75e-05 | 4 | 76 | 2 | IPR019590 |
| Domain | PDZ_assoc | DLG1 DLG4 | 9.75e-05 | 4 | 76 | 2 | IPR019583 |
| Domain | MAGUK_N_PEST | DLG1 DLG4 | 9.75e-05 | 4 | 76 | 2 | SM01277 |
| Domain | DLG1 | DLG1 DLG4 | 9.75e-05 | 4 | 76 | 2 | IPR016313 |
| Domain | DUF4704 | NBEAL1 NBEAL2 | 1.62e-04 | 5 | 76 | 2 | IPR031570 |
| Domain | DUF4704 | NBEAL1 NBEAL2 | 1.62e-04 | 5 | 76 | 2 | PF15787 |
| Domain | PH_BEACH | NBEAL1 NBEAL2 | 2.43e-04 | 6 | 76 | 2 | PF14844 |
| Domain | PH-BEACH_dom | NBEAL1 NBEAL2 | 4.50e-04 | 8 | 76 | 2 | IPR023362 |
| Domain | - | NBEAL1 NBEAL2 | 4.50e-04 | 8 | 76 | 2 | 2.30.29.40 |
| Domain | PH_BEACH | NBEAL1 NBEAL2 | 4.50e-04 | 8 | 76 | 2 | PS51783 |
| Domain | SH3_1 | ARHGAP10 DLG1 DLG4 NEB FUT8 | 5.49e-04 | 164 | 76 | 5 | PF00018 |
| Domain | BEACH_dom | NBEAL1 NBEAL2 | 5.77e-04 | 9 | 76 | 2 | IPR000409 |
| Domain | BEACH | NBEAL1 NBEAL2 | 5.77e-04 | 9 | 76 | 2 | PS50197 |
| Domain | Beach | NBEAL1 NBEAL2 | 5.77e-04 | 9 | 76 | 2 | PF02138 |
| Domain | - | NBEAL1 NBEAL2 | 5.77e-04 | 9 | 76 | 2 | 1.10.1540.10 |
| Domain | Beach | NBEAL1 NBEAL2 | 5.77e-04 | 9 | 76 | 2 | SM01026 |
| Domain | TIL | MUC5AC MUC6 | 1.05e-03 | 12 | 76 | 2 | PF01826 |
| Domain | C8 | MUC5AC MUC6 | 1.05e-03 | 12 | 76 | 2 | PF08742 |
| Domain | Unchr_dom_Cys-rich | MUC5AC MUC6 | 1.24e-03 | 13 | 76 | 2 | IPR014853 |
| Domain | C8 | MUC5AC MUC6 | 1.24e-03 | 13 | 76 | 2 | SM00832 |
| Domain | TIL_dom | MUC5AC MUC6 | 1.44e-03 | 14 | 76 | 2 | IPR002919 |
| Domain | SH3 | ARHGAP10 DLG1 DLG4 NEB FUT8 | 1.88e-03 | 216 | 76 | 5 | SM00326 |
| Domain | SH3 | ARHGAP10 DLG1 DLG4 NEB FUT8 | 1.88e-03 | 216 | 76 | 5 | PS50002 |
| Domain | Post-SET_dom | KMT2B SUV39H1 | 1.89e-03 | 16 | 76 | 2 | IPR003616 |
| Domain | VWD | MUC5AC MUC6 | 1.89e-03 | 16 | 76 | 2 | SM00216 |
| Domain | PostSET | KMT2B SUV39H1 | 1.89e-03 | 16 | 76 | 2 | SM00508 |
| Domain | Guanylate_kinase_CS | DLG1 DLG4 | 1.89e-03 | 16 | 76 | 2 | IPR020590 |
| Domain | VWF_type-D | MUC5AC MUC6 | 1.89e-03 | 16 | 76 | 2 | IPR001846 |
| Domain | VWFD | MUC5AC MUC6 | 1.89e-03 | 16 | 76 | 2 | PS51233 |
| Domain | POST_SET | KMT2B SUV39H1 | 1.89e-03 | 16 | 76 | 2 | PS50868 |
| Domain | VWD | MUC5AC MUC6 | 1.89e-03 | 16 | 76 | 2 | PF00094 |
| Domain | SH3_domain | ARHGAP10 DLG1 DLG4 NEB FUT8 | 2.03e-03 | 220 | 76 | 5 | IPR001452 |
| Domain | - | WDHD1 NBEAL1 NBEAL2 WDR1 WDR13 PLXNB3 | 2.36e-03 | 333 | 76 | 6 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | WDHD1 NBEAL1 NBEAL2 WDR1 WDR13 PLXNB3 | 2.43e-03 | 335 | 76 | 6 | IPR015943 |
| Domain | VWC_out | MUC5AC MUC6 | 2.67e-03 | 19 | 76 | 2 | SM00215 |
| Domain | CT | MUC5AC MUC6 | 3.58e-03 | 22 | 76 | 2 | SM00041 |
| Domain | GUANYLATE_KINASE_2 | DLG1 DLG4 | 3.91e-03 | 23 | 76 | 2 | PS50052 |
| Domain | GUANYLATE_KINASE_1 | DLG1 DLG4 | 3.91e-03 | 23 | 76 | 2 | PS00856 |
| Domain | SH3_9 | ARHGAP10 NEB FUT8 | 3.96e-03 | 78 | 76 | 3 | PF14604 |
| Domain | WD40 | WDHD1 NBEAL1 NBEAL2 WDR1 WDR13 | 4.09e-03 | 259 | 76 | 5 | PF00400 |
| Domain | Cys_knot_C | MUC5AC MUC6 | 4.61e-03 | 25 | 76 | 2 | IPR006207 |
| Domain | CTCK_2 | MUC5AC MUC6 | 4.61e-03 | 25 | 76 | 2 | PS01225 |
| Domain | WD40 | WDHD1 NBEAL1 NBEAL2 WDR1 WDR13 | 4.73e-03 | 268 | 76 | 5 | SM00320 |
| Domain | Guanylate_kin | DLG1 DLG4 | 4.99e-03 | 26 | 76 | 2 | PF00625 |
| Domain | GK/Ca_channel_bsu | DLG1 DLG4 | 4.99e-03 | 26 | 76 | 2 | IPR008145 |
| Domain | Guanylate_kin-like_dom | DLG1 DLG4 | 4.99e-03 | 26 | 76 | 2 | IPR008144 |
| Domain | GuKc | DLG1 DLG4 | 4.99e-03 | 26 | 76 | 2 | SM00072 |
| Domain | WD40_repeat | WDHD1 NBEAL1 NBEAL2 WDR1 WDR13 | 5.03e-03 | 272 | 76 | 5 | IPR001680 |
| Domain | WD_REPEATS_1 | WDHD1 NBEAL1 NBEAL2 WDR1 WDR13 | 5.51e-03 | 278 | 76 | 5 | PS00678 |
| Domain | WD_REPEATS_2 | WDHD1 NBEAL1 NBEAL2 WDR1 WDR13 | 5.59e-03 | 279 | 76 | 5 | PS50082 |
| Domain | WD_REPEATS_REGION | WDHD1 NBEAL1 NBEAL2 WDR1 WDR13 | 5.59e-03 | 279 | 76 | 5 | PS50294 |
| Domain | Calcineurin-like_PHP_ApaH | SMPDL3A MPPE1 | 5.77e-03 | 28 | 76 | 2 | IPR004843 |
| Domain | Metallophos | SMPDL3A MPPE1 | 5.77e-03 | 28 | 76 | 2 | PF00149 |
| Domain | Metallo-depent_PP-like | SMPDL3A MPPE1 | 6.60e-03 | 30 | 76 | 2 | IPR029052 |
| Domain | - | SMPDL3A MPPE1 | 6.60e-03 | 30 | 76 | 2 | 3.60.21.10 |
| Domain | WD40_repeat_dom | WDHD1 NBEAL1 NBEAL2 WDR1 WDR13 | 7.24e-03 | 297 | 76 | 5 | IPR017986 |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.46e-29 | 45 | 64 | 17 | MM15671 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 DLG1 DLG4 USP17L10 USP17L19 USP17L22 KIT USP17L15 USP17L13 USP17L18 | 5.13e-18 | 318 | 64 | 20 | MM15278 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 6.73e-18 | 191 | 64 | 17 | MM15289 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.42e-15 | 262 | 64 | 17 | MM15286 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.94e-15 | 221 | 64 | 16 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.20e-13 | 299 | 64 | 16 | M27574 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 ART4 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 SAE1 USP17L5 FBXO11 USP17L10 USP17L19 FUT8 USP17L22 MUC5AC MUC6 ARSI USP17L15 USP17L13 USP17L18 | 2.97e-09 | 1389 | 64 | 24 | MM15307 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 USP17L2 USP17L12 USP17L1 ART4 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 SAE1 USP17L5 FBXO11 USP17L10 USP17L19 FUT8 USP17L22 MUC5AC MUC6 ARSI USP17L15 USP17L13 USP17L18 | 5.05e-08 | 1475 | 64 | 23 | M19806 |
| Pathway | REACTOME_NRCAM_INTERACTIONS | DLG1 DLG4 | 4.20e-04 | 7 | 64 | 2 | M27378 |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | DLG1 DLG4 | 8.92e-04 | 10 | 64 | 2 | M10272 |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.35e-42 | 21 | 80 | 17 | 8622927 |
| Pubmed | DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.35e-42 | 21 | 80 | 17 | 14583620 |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.35e-42 | 21 | 80 | 17 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.35e-42 | 21 | 80 | 17 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.35e-42 | 21 | 80 | 17 | 12447969 |
| Pubmed | DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.35e-42 | 21 | 80 | 17 | 18980247 |
| Pubmed | JAK2 is required for induction of the murine DUB-1 gene. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 5.94e-42 | 22 | 80 | 17 | 9154835 |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 7.78e-41 | 24 | 80 | 17 | 8995226 |
| Pubmed | Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.43e-40 | 25 | 80 | 17 | 21115691 |
| Pubmed | Cdc25A and Dub3 in a high-stakes balancing act. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.17e-40 | 33 | 80 | 18 | 20228807 |
| Pubmed | Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 7.00e-40 | 26 | 80 | 17 | 35816173 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 8.84e-40 | 34 | 80 | 18 | 20403174 |
| Pubmed | Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 8.84e-40 | 34 | 80 | 18 | 17109758 |
| Pubmed | The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 8.84e-40 | 34 | 80 | 18 | 20388806 |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 8.84e-40 | 34 | 80 | 18 | 14699124 |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 8.84e-40 | 34 | 80 | 18 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 8.84e-40 | 34 | 80 | 18 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 8.84e-40 | 34 | 80 | 18 | 20368735 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 8.84e-40 | 34 | 80 | 18 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 8.84e-40 | 34 | 80 | 18 | 19188362 |
| Pubmed | Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 8.84e-40 | 34 | 80 | 18 | 11941478 |
| Pubmed | The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 8.84e-40 | 34 | 80 | 18 | 10936051 |
| Pubmed | The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 8.84e-40 | 34 | 80 | 18 | 21448158 |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.82e-39 | 35 | 80 | 18 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.82e-39 | 35 | 80 | 18 | 21239494 |
| Pubmed | The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 3.63e-39 | 36 | 80 | 18 | 20147298 |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 7.05e-39 | 37 | 80 | 18 | 20228808 |
| Pubmed | Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.16e-38 | 29 | 80 | 17 | 32527007 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.12e-33 | 50 | 80 | 17 | 31806660 |
| Pubmed | USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities. | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 ETV1 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 LGALS7 USP17L13 USP17L18 | 8.64e-16 | 674 | 80 | 19 | 37196079 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | USP17L7 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 | 2.55e-14 | 10 | 80 | 6 | 24207026 |
| Pubmed | Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells. | USP17L7 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 | 1.12e-13 | 12 | 80 | 6 | 24695638 |
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | USP17L7 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 | 3.62e-13 | 14 | 80 | 6 | 11793228 |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | USP17L7 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 | 3.24e-12 | 19 | 80 | 6 | 28067227 |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L19 USP17L18 | 1.19e-08 | 119 | 80 | 7 | 28625976 |
| Pubmed | Human and mouse proteases: a comparative genomic approach. | USP17L7 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 | 3.46e-08 | 81 | 80 | 6 | 12838346 |
| Pubmed | Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. | USP17L2 USP17L15 USP17L13 | 4.68e-08 | 4 | 80 | 3 | 22984479 |
| Pubmed | ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours. | ETV1 KIT | 5.23e-06 | 2 | 80 | 2 | 20927104 |
| Pubmed | Clinicopathological features of superficial non-ampurally duodenal epithelial tumor; gastric phenotype of histology correlates to higher malignant potency. | MUC5AC MUC6 | 5.23e-06 | 2 | 80 | 2 | 28321513 |
| Pubmed | Human mucin genes MUC2, MUC3, MUC4, MUC5AC, MUC5B, and MUC6 express stable and extremely large mRNAs and exhibit a variable length polymorphism. An improved method to analyze large mRNAs. | MUC5AC MUC6 | 5.23e-06 | 2 | 80 | 2 | 9422745 |
| Pubmed | Expression of Kit and Etv1 in restricted brain regions supports a brain-cell progenitor as an origin for cranial germinomas. | ETV1 KIT | 5.23e-06 | 2 | 80 | 2 | 25736805 |
| Pubmed | Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. | MUC5AC MUC6 | 5.23e-06 | 2 | 80 | 2 | 12360467 |
| Pubmed | Expression of CD133 and CD117 in 64 Serous Ovarian Cancer Cases. | PROM1 KIT | 5.23e-06 | 2 | 80 | 2 | 26898076 |
| Pubmed | Interaction between SAP97 and PSD-95, two Maguk proteins involved in synaptic trafficking of AMPA receptors. | DLG1 DLG4 | 5.23e-06 | 2 | 80 | 2 | 16332687 |
| Pubmed | Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution. | MUC5AC MUC6 | 5.23e-06 | 2 | 80 | 2 | 11988092 |
| Pubmed | Clustering and enhanced activity of an inwardly rectifying potassium channel, Kir4.1, by an anchoring protein, PSD-95/SAP90. | DLG1 DLG4 | 1.57e-05 | 3 | 80 | 2 | 9148889 |
| Pubmed | Mucin expression in reactive gastropathy: an immunohistochemical analysis. | MUC5AC MUC6 | 1.57e-05 | 3 | 80 | 2 | 17227128 |
| Pubmed | The cytoplasmic domain of NrCAM binds to PDZ domains of synapse-associated proteins SAP90/PSD95 and SAP97. | DLG1 DLG4 | 1.57e-05 | 3 | 80 | 2 | 16882004 |
| Pubmed | Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth. | ETV1 KIT | 1.57e-05 | 3 | 80 | 2 | 25572173 |
| Pubmed | Targeting of PKA to glutamate receptors through a MAGUK-AKAP complex. | DLG1 DLG4 | 1.57e-05 | 3 | 80 | 2 | 10939335 |
| Pubmed | Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis. | MUC5AC MUC6 | 1.57e-05 | 3 | 80 | 2 | 23828549 |
| Pubmed | The utility of CD44, CD117 and CD133 in identification of cancer stem cells (CSC) in oral squamous cell carcinomas (OSCC). | PROM1 KIT | 1.57e-05 | 3 | 80 | 2 | 22119814 |
| Pubmed | Overexpression of angiopoietin-1 increases CD133+/c-kit+ cells and reduces myocardial apoptosis in db/db mouse infarcted hearts. | PROM1 KIT | 1.57e-05 | 3 | 80 | 2 | 22558265 |
| Pubmed | Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma. | MUC5AC MUC6 | 1.57e-05 | 3 | 80 | 2 | 18825309 |
| Pubmed | GAKIN, a novel kinesin-like protein associates with the human homologue of the Drosophila discs large tumor suppressor in T lymphocytes. | DLG1 DLG4 | 1.57e-05 | 3 | 80 | 2 | 10859302 |
| Pubmed | A specific N-terminal residue in Kv1.5 is required for upregulation of the channel by SAP97. | DLG1 DLG4 | 1.57e-05 | 3 | 80 | 2 | 16466689 |
| Pubmed | The receptor protein tyrosine phosphatase, PTP-RO, is upregulated during megakaryocyte differentiation and Is associated with the c-Kit receptor. | PTPRU KIT | 1.57e-05 | 3 | 80 | 2 | 10397721 |
| Pubmed | Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia. | MUC5AC MUC6 | 1.57e-05 | 3 | 80 | 2 | 18300795 |
| Pubmed | A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer. | MUC5AC MUC6 | 1.57e-05 | 3 | 80 | 2 | 19924550 |
| Pubmed | Mir-152 inhibits cell proliferation and colony formation of CD133(+) liver cancer stem cells by targeting KIT. | PROM1 KIT | 1.57e-05 | 3 | 80 | 2 | 25311946 |
| Pubmed | The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer. | PROM1 KIT | 1.57e-05 | 3 | 80 | 2 | 22199321 |
| Pubmed | Differential interaction of the tSXV motifs of the NR1 and NR2A NMDA receptor subunits with PSD-95 and SAP97. | DLG1 DLG4 | 1.57e-05 | 3 | 80 | 2 | 10336672 |
| Pubmed | Molecular portraits of heterogeneity related to cancer stem cells in human ovarian cancer. | PROM1 KIT | 1.57e-05 | 3 | 80 | 2 | 24300467 |
| Pubmed | Intramolecular interactions regulate SAP97 binding to GKAP. | DLG1 DLG4 | 1.57e-05 | 3 | 80 | 2 | 11060025 |
| Pubmed | BEGAIN (brain-enriched guanylate kinase-associated protein), a novel neuronal PSD-95/SAP90-binding protein. | DLG1 DLG4 | 1.57e-05 | 3 | 80 | 2 | 9756850 |
| Pubmed | Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1. | ETV1 KIT | 1.57e-05 | 3 | 80 | 2 | 25865047 |
| Pubmed | An inhibitor of the acetyltransferases CBP/p300 exerts antineoplastic effects on gastrointestinal stromal tumor cells. | ETV1 KIT | 3.13e-05 | 4 | 80 | 2 | 27633918 |
| Pubmed | Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. | DLG1 DLG4 | 3.13e-05 | 4 | 80 | 2 | 9326658 |
| Pubmed | Molecular mechanisms regulating the differential association of kainate receptor subunits with SAP90/PSD-95 and SAP97. | DLG1 DLG4 | 3.13e-05 | 4 | 80 | 2 | 11279111 |
| Pubmed | Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas. | MUC5AC MUC6 | 3.13e-05 | 4 | 80 | 2 | 33154304 |
| Pubmed | Gastric mucin expression in first-degree relatives of gastric cancer patients. | MUC5AC MUC6 | 3.13e-05 | 4 | 80 | 2 | 24901817 |
| Pubmed | Lano, a novel LAP protein directly connected to MAGUK proteins in epithelial cells. | DLG1 DLG4 | 3.13e-05 | 4 | 80 | 2 | 11440998 |
| Pubmed | Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS). | MUC5AC MUC6 | 3.13e-05 | 4 | 80 | 2 | 36367122 |
| Pubmed | Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. | MUC5AC MUC6 | 3.13e-05 | 4 | 80 | 2 | 17471237 |
| Pubmed | The mouse secreted gel-forming mucin gene cluster. | MUC5AC MUC6 | 3.13e-05 | 4 | 80 | 2 | 14984930 |
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | MUC5AC MUC6 | 3.13e-05 | 4 | 80 | 2 | 29869461 |
| Pubmed | Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? | MUC5AC MUC6 | 3.13e-05 | 4 | 80 | 2 | 20929551 |
| Pubmed | Ggamma13 interacts with PDZ domain-containing proteins. | DLG1 DLG4 | 3.13e-05 | 4 | 80 | 2 | 16473877 |
| Pubmed | Muscarinic-induced recruitment of plasma membrane Ca2+-ATPase involves PSD-95/Dlg/Zo-1-mediated interactions. | DLG1 DLG4 | 3.13e-05 | 4 | 80 | 2 | 19017653 |
| Pubmed | Cypin: a cytosolic regulator of PSD-95 postsynaptic targeting. | DLG1 DLG4 | 3.13e-05 | 4 | 80 | 2 | 10595517 |
| Pubmed | GKAP, a novel synaptic protein that interacts with the guanylate kinase-like domain of the PSD-95/SAP90 family of channel clustering molecules. | DLG1 DLG4 | 3.13e-05 | 4 | 80 | 2 | 9024696 |
| Pubmed | Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma. | MUC5AC MUC6 | 3.13e-05 | 4 | 80 | 2 | 24603585 |
| Pubmed | Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. | MUC5AC MUC6 | 3.13e-05 | 4 | 80 | 2 | 23807779 |
| Pubmed | Expression pattern of membrane-associated guanylate kinases in interneurons of the visual cortex. | DLG1 DLG4 | 3.13e-05 | 4 | 80 | 2 | 21031555 |
| Pubmed | A role for myosin VI in postsynaptic structure and glutamate receptor endocytosis. | DLG1 DLG4 | 3.13e-05 | 4 | 80 | 2 | 15657400 |
| Pubmed | Synaptic scaffold evolution generated components of vertebrate cognitive complexity. | DLG1 DLG4 | 3.13e-05 | 4 | 80 | 2 | 23201973 |
| Pubmed | MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. | MUC5AC MUC6 | 3.13e-05 | 4 | 80 | 2 | 27298226 |
| Pubmed | Association of the kinesin superfamily motor protein KIF1Balpha with postsynaptic density-95 (PSD-95), synapse-associated protein-97, and synaptic scaffolding molecule PSD-95/discs large/zona occludens-1 proteins. | DLG1 DLG4 | 3.13e-05 | 4 | 80 | 2 | 12097473 |
| Pubmed | Postsynaptic targeting of alternative postsynaptic density-95 isoforms by distinct mechanisms. | DLG1 DLG4 | 3.13e-05 | 4 | 80 | 2 | 12151521 |
| Pubmed | Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. | MUC5AC MUC6 | 3.13e-05 | 4 | 80 | 2 | 17401217 |
| Pubmed | Characterization of mouse muc6 and evidence of conservation of the gel-forming mucin gene cluster between human and mouse. | MUC5AC MUC6 | 3.13e-05 | 4 | 80 | 2 | 12676567 |
| Pubmed | Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours. | MUC5AC MUC6 | 3.13e-05 | 4 | 80 | 2 | 25298197 |
| Pubmed | Sema4c, a transmembrane semaphorin, interacts with a post-synaptic density protein, PSD-95. | DLG1 DLG4 | 5.20e-05 | 5 | 80 | 2 | 11134026 |
| Pubmed | Localization of postsynaptic density-93 to dendritic microtubules and interaction with microtubule-associated protein 1A. | DLG1 DLG4 | 5.20e-05 | 5 | 80 | 2 | 9786987 |
| Pubmed | Selective interaction of megalin with postsynaptic density-95 (PSD-95)-like membrane-associated guanylate kinase (MAGUK) proteins. | DLG1 DLG4 | 5.20e-05 | 5 | 80 | 2 | 12713445 |
| Pubmed | Glutamatergic neurons induce expression of functional glutamatergic synapses in primary myotubes. | DLG1 DLG4 | 5.20e-05 | 5 | 80 | 2 | 22347480 |
| Pubmed | SAP97 increases Kv1.5 currents through an indirect N-terminal mechanism. | DLG1 DLG4 | 5.20e-05 | 5 | 80 | 2 | 12860415 |
| Pubmed | Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus? | MUC5AC MUC6 | 5.20e-05 | 5 | 80 | 2 | 22261707 |
| Pubmed | Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases. | DLG1 DLG4 | 5.20e-05 | 5 | 80 | 2 | 8601796 |
| Pubmed | SAP90 binds and clusters kainate receptors causing incomplete desensitization. | DLG1 DLG4 | 5.20e-05 | 5 | 80 | 2 | 9808460 |
| Cytoband | 4p16.1 | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 WDR1 USP17L22 USP17L15 USP17L13 USP17L18 | 5.08e-27 | 79 | 80 | 15 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L5 USP17L10 USP17L19 WDR1 USP17L22 USP17L15 USP17L13 USP17L18 | 5.76e-20 | 222 | 80 | 15 | chr4p16 |
| Cytoband | 8p23.1 | USP17L7 USP17L2 USP17L1 USP17L3 | 1.58e-04 | 154 | 80 | 4 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | USP17L7 USP17L2 USP17L1 USP17L3 | 7.68e-04 | 234 | 80 | 4 | chr8p23 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q23 | PLEKHG3 FUT8 PPM1A | 1.55e-03 | 130 | 80 | 3 | chr14q23 |
| GeneFamily | WD repeat domain containing|BEACH domain containing | NBEAL1 NBEAL2 | 2.56e-04 | 9 | 49 | 2 | 1230 |
| GeneFamily | Fucosyltransferases|Blood group antigens | FUT9 FUT8 | 5.51e-04 | 13 | 49 | 2 | 434 |
| GeneFamily | WD repeat domain containing | WDHD1 NBEAL1 NBEAL2 WDR1 WDR13 | 6.97e-04 | 262 | 49 | 5 | 362 |
| GeneFamily | CD molecules|Mucins | MUC5AC MUC6 | 1.46e-03 | 21 | 49 | 2 | 648 |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | DLG1 DLG4 | 2.24e-03 | 26 | 49 | 2 | 904 |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | KMT2B SUV39H1 | 3.82e-03 | 34 | 49 | 2 | 487 |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 7.49e-27 | 86 | 79 | 17 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 CASP6 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.20e-26 | 112 | 79 | 18 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 5.48e-22 | 160 | 79 | 17 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 NBEAL2 ANKRD10 USP17L6P USP17L3 USP17L5 USP17L10 REN USP17L19 USP17L22 USP17L15 PPM1A USP17L13 USP17L18 | 2.47e-16 | 647 | 79 | 21 | MM981 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 NBEAL2 ANKRD10 USP17L6P USP17L3 USP17L5 USP17L10 REN USP17L19 USP17L22 USP17L15 PPM1A USP17L13 USP17L18 | 5.52e-11 | 1226 | 79 | 21 | MM979 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 USP17L21 SYNRG USP17L2 USP17L12 USP17L1 USP17L17 ARHGAP10 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 3.09e-10 | 1072 | 79 | 19 | MM1031 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 CLPB USP17L17 USP17L20 USP17L11 USP17L6P USP17L3 USP17L5 PDIA5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.95e-09 | 1198 | 79 | 19 | MM1062 |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; HL60; HT_HG-U133A | SMPDL3A C2orf42 DLG1 FBXO11 WDR1 NEB MAP3K2 | 1.34e-06 | 194 | 65 | 7 | 1294_UP |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 9.78e-36 | 46 | 77 | 18 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L21 USP17L2 KMT2B USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L6P USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 3.08e-34 | 69 | 77 | 19 | DOID:1682 (implicated_via_orthology) |
| Disease | mucinous adenocarcinoma (is_marker_for) | MUC5AC MUC6 | 6.69e-05 | 5 | 77 | 2 | DOID:3030 (is_marker_for) |
| Disease | benign neoplasm (implicated_via_orthology) | DLG1 DLG4 | 1.86e-04 | 8 | 77 | 2 | DOID:0060072 (implicated_via_orthology) |
| Disease | renin measurement | NBEAL1 REN | 1.86e-04 | 8 | 77 | 2 | EFO_0010616 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | DLG1 DLG4 PLXNB3 | 2.89e-04 | 49 | 77 | 3 | DOID:0060037 (implicated_via_orthology) |
| Disease | gastric ulcer (implicated_via_orthology) | MUC5AC MUC6 | 5.99e-04 | 14 | 77 | 2 | DOID:10808 (implicated_via_orthology) |
| Disease | dystonia (is_implicated_in) | KMT2B TMEM151A | 5.99e-04 | 14 | 77 | 2 | DOID:543 (is_implicated_in) |
| Disease | cholangiocarcinoma (is_marker_for) | KIT MUC5AC MUC6 | 6.35e-04 | 64 | 77 | 3 | DOID:4947 (is_marker_for) |
| Disease | carcinoma (implicated_via_orthology) | DLG1 DLG4 KIT | 6.35e-04 | 64 | 77 | 3 | DOID:305 (implicated_via_orthology) |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | KMT2B DLG4 | 8.91e-04 | 17 | 77 | 2 | DOID:0060307 (is_implicated_in) |
| Disease | PR interval | MYO3A ARHGEF40 DLG1 ASTN2 FBXO11 SIPA1L2 | 1.88e-03 | 495 | 77 | 6 | EFO_0004462 |